Cargando…

Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1

BACKGROUND: Low-grade gliomas (LGGs) occurring in children can result in many different neurologic complications, including seizures. MEK inhibitors are increasingly being used to treat LGG, but their effect on associated neurologic symptoms has not been established. RESULTS: Here, we report a patie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cantor, Evan, Meyer, Ashley, Morris, Stephanie M., Weisenberg, Judith L. Z., Brossier, Nicole M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9617819/ https://www.ncbi.nlm.nih.gov/pubmed/35648241 http://dx.doi.org/10.1007/s00381-022-05571-y

Ejemplares similares

LGG-38. Dose-dependent seizure control for an NF1 patient treated via MEK-inhibition for optic pathway glioma
por: Cantor, Evan, et al.
Publicado: (2022)

OTHR-09. The prevalence and complex management of MEK inhibitor induced cutaneous side effects
por: Meyer, Ashley, et al.
Publicado: (2022)

LGG-02. Cardiac toxicity in patients receiving single-agent MEK inhibition
por: Cantor, Evan, et al.
Publicado: (2022)

LGG-28. Rapid symptomatic improvement for a patient treated with BRAF inhibition for BRAFV600E mutated ganglioglioma
por: Cantor, Evan, et al.
Publicado: (2022)

LGG-21. Durability of response to targeted therapies in pediatric low-grade gliomas: A multi-institution retrospective review
por: Cantor, Evan, et al.
Publicado: (2022)

Glioma-Induced Seizure in a Neurofibromatosis Type 1 Patient: A Case Report
por: Quinonez, Jonathan, et al.
Publicado: (2021)

GCT-14. The Impact of Residual Disease on the Outcomes of Central Nervous System Germinomas – A Single Institution Experience
por: Cantor, Evan, et al.
Publicado: (2022)

LGG-39. Ascites in a medullary and leptomeningeal ganglioglioma patient following cisplatin treatment necessitating cessation of therapy and conversion to VA shunt
por: Cantor, Evan, et al.
Publicado: (2022)

Profile of ezogabine (retigabine) and its potential as an adjunctive treatment for patients with partial-onset seizures
por: Weisenberg, Judith LZ, et al.
Publicado: (2011)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

The Use of MEK Inhibitors in Neurofibromatosis Type 1–Associated Tumors and Management of Toxicities
por: Klesse, Laura J., et al.
Publicado: (2020)

Optic Nerve Glioma in Neurofibromatosis: Radiological Clues to Diagnosis in a Young Child
por: Patel, Harsh, et al.
Publicado: (2021)

MEK inhibitors - novel targeted therapies of neurofibromatosis associated benign and malignant lesions
por: Harder, Anja
Publicado: (2021)

High-Dose Intravenous Vitamin C Treatment of a Child with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Case Report
por: Mikirova, Nina, et al.
Publicado: (2016)

MEK inhibition exerts temporal and myeloid cell-specific effects in the pathogenesis of neurofibromatosis type 1 arteriopathy
por: Tritz, Rebekah, et al.
Publicado: (2021)

RARE-27. Treatment and outcomes in atypical choroid plexus papilloma: a single institution experience
por: Cluster, Andrew, et al.
Publicado: (2022)

An Update on Neurofibromatosis Type 1-Associated Gliomas
por: Lobbous, Mina, et al.
Publicado: (2020)

Concurrent inhibition of FAK/SRC and MEK overcomes MEK inhibitor resistance in Neurofibromatosis Type I related malignant peripheral nerve sheath tumors
por: Gu, Yihui, et al.
Publicado: (2022)

Non-optic glioma in adults and children with neurofibromatosis 1
por: Sellmer, Laura, et al.
Publicado: (2017)

Treatment decisions and the use of MEK inhibitors for children with neurofibromatosis type 1-related plexiform neurofibromas
por: Armstrong, Amy E., et al.
Publicado: (2023)

Rare Case of Optic Pathway Glioma with Extensive Intra-Ocular Involvement in a Child with Neurofibromatosis Type 1
por: Gupta, Vasudha, et al.
Publicado: (2015)

MEDB-54. Standard Risk Medulloblastoma treated solely with surgery and chemo-radiation
por: Cantor, Evan, et al.
Publicado: (2022)

MRI Screening for Optic Gliomas in Neurofibromatosis Type 1
por: Millichap, J. Gordon
Publicado: (2015)

LGG-30. TRAMETINIB-ASSOCIATED HYPONATREMIA IN A CHILD WITH LOW GRADE GLIOMA IS NOT SEEN FOLLOWING TREATMENT WITH ALTERNATIVE MEK INHIBITOR
por: Lazow, Margot A, et al.
Publicado: (2020)

NFB-02. Maternal high-fat diet exposure increases the proliferation and glial differentiation of the cells of origin for NF1-optic glioma
por: Zhang, Kailong, et al.
Publicado: (2022)

Neurofibromatosis type 1 of the child increases birth weight
por: Leppävirta, Jussi, et al.
Publicado: (2019)

Neurofibromas of the bladder in a child with neurofibromatosis type 1
por: Dogan, Gulec Mert, et al.
Publicado: (2018)

Ewing sarcoma in a child with neurofibromatosis type 1
por: Fernandez, Karen S., et al.
Publicado: (2019)

BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant glioma
por: Funck-Brentano, Elisa, et al.
Publicado: (2020)

De novo development of gliomas in a child with neurofibromatosis type 1, fragile X and previously normal brain magnetic resonance imaging
por: Zafar, Rabia, et al.
Publicado: (2016)

NFB-23. Extent of tumor but not location may be predictive of longitudinal disease severity in children with NF1-associated gliomas requiring treatment
por: Chaturvedi, Sneha, et al.
Publicado: (2022)

Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome
por: Vurallı, Doğuş, et al.
Publicado: (2016)

Congenital Pseudoarthrosis Tibia with Fibrous Hamartoma in a Child with Neurofibromatosis
por: Pujani, Meenu, et al.
Publicado: (2013)

Natural History of Medulloblastoma in a Child with Neurofibromatosis Type I
por: Golpayegani, Mehdi, et al.
Publicado: (2018)

Subepidermal Calcified Nodule in a Child With Neurofibromatosis Type 1
por: Bagci, Buket, et al.
Publicado: (2022)

Ovarian Cell Tumor in a Child with Neurofibromatosis Type 1
por: Qutub, Lujain Majdi, et al.
Publicado: (2022)

Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
por: Sweeney, Elizabeth E., et al.
Publicado: (2016)

Optic Pathway Glioma in Children with Neurofibromatosis Type 1: A Multidisciplinary Entity, Posing Dilemmas in Diagnosis and Management Multidisciplinary Management of Optic Pathway Glioma in Children with Neurofibromatosis Type 1
por: Lohkamp, Laura-Nanna, et al.
Publicado: (2022)

Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis: Abscess Formation in the Tumor Leading to Bacteremia and Seizure
por: Kitagawa, Maki, et al.
Publicado: (2010)

Neurofibromatosis
por: Gerber, PA, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_cro7qhua0u347k407g5ff4d141